These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6967335)

  • 1. [Study of peripheral blood T-lymphocytes by the spontaneous and active "rosette" method using levamisole].
    Liapon AO; Lebedev KA; Mashkilleĭson AL
    Biull Eksp Biol Med; 1980 May; 89(5):630-2. PubMed ID: 6967335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of E-rosette formation by levamisole and its abrogation by autochthonous serum from cattle with squamous cell carcinoma of horn.
    Dhingra VK; Gupta RK; Sadana JR
    Res Vet Sci; 1982 Sep; 33(2):142-5. PubMed ID: 6983096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro effect of levamisole on histamine inhibited E-rosette forming T-lymphocyte subpopulation in patients affected by disseminated erythematosus lupus.
    Pozsonyi T; Jakab L; Fehér J; Cseh K
    Allergol Immunopathol (Madr); 1982; 10(6):435-9. PubMed ID: 6220589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations.
    Pozsonyi T; Fehér J; Jakab L
    Allergol Immunopathol (Madr); 1981; 9(1):37-44. PubMed ID: 6973266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of levamisole on E-rosette formation by trypsinized lymphocytes.
    Lomnitzer R; Rabson AR
    Clin Exp Immunol; 1978 Sep; 33(3):499-502. PubMed ID: 310743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of azathioprine and levamisole on rosette-forming cells of healthy subjects and cancer patients.
    Verhaegen H; De Cock W; De Cree J
    Clin Exp Immunol; 1977 Aug; 29(2):311-5. PubMed ID: 908176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of levamisole on the activity of the blood T-lymphocytes and of factors they produce in patients with laryngeal cancer].
    Volosevich LI; Lukach EV; Krivokhatskaia LD
    Eksp Onkol; 1988; 10(3):54-7. PubMed ID: 2970382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T- and B-lymphocytes in pemphigus vulgaris. A clinico-immunological follow-up study of fifty patients with pemphigus vulgaris.
    Mashkilleyson N
    Acta Derm Venereol; 1987; 67(3):218-24. PubMed ID: 2442934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levamisole treatment of inflammatory acne. Restoration of impaired T-cell function accompanied by clearing of the lesions.
    De Cree J; De Cock W; Verhaegen H
    Biomedicine; 1979 Jul; 31(4):95-9. PubMed ID: 158397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the E-rosette formation of T-lymphocytes by aggregated human IgG and restoration by levamisole.
    De Cock W; De Cree J; Verhaegen H
    Immunology; 1978 Aug; 35(2):223-7. PubMed ID: 312252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the in vitro effects of thymopoietin pentapeptide and levamisole on peripheral E-rosette forming cells.
    Verhaegen H; De Cock W; De Cree J; Goldstein G
    Thymus; 1980 Jan; 1(4-5):195-204. PubMed ID: 7445020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of levamisole on spontaneous rosette-forming cells in murine spleen.
    van Ginckel RF; Hoebeke J
    Eur J Immunol; 1976 Apr; 6(4):305-7. PubMed ID: 1086780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of formation of active T-rosette forming cells in multiple sclerosis patients].
    Matveeva TV; D'iakonova IN; Shaĭdullina FS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):21-5. PubMed ID: 6972132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some T-cell functions in patients with viral myocarditis. The effect of levamisole.
    Goch JH; Czernicki J; Offierska M
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):395-404. PubMed ID: 6223612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levamisole in the treatment of Hodgkin's disease.
    Berényi E; Kávai M; Szabolcsi M; Szegedi G
    Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytes T and pharmacokinetics after a single oral dose of levamisole in healthy and cancer subjects.
    Luyckx M; Cazin M; Brunet C; Cazin JC; Devulder B; Gosselin P; Adenis L; Cappelaere P; Granier AM; Demaille A
    Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):467-9. PubMed ID: 6608036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T; Jakab L; Fehér J
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of levamisole on E-rosette formation by T-lymphocytes of uremic patients.
    Modai D; Peller S; Cohen N; Shaked U; Kaufman S
    Isr J Med Sci; 1983 Mar; 19(3):289-91. PubMed ID: 6303981
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of levamisole on autologous rosette-forming cells in nude mice.
    Van Wauwe J; Van Nijen G
    Clin Exp Immunol; 1977 Dec; 30(3):465-8. PubMed ID: 304789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levamisole and human lymphocyte surface markers.
    Wybran J; Govaerts A
    Clin Exp Immunol; 1977 Feb; 27(2):319-21. PubMed ID: 321166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.